Endo International plc Business Finance Contracts & Agreements

141 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Purchase and Sale Agreement among Endo Enterprise, Inc., Endo USA, Inc., Paladin Pharma Inc., and Endo International plc (April 14, 2024)
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2024
Indenture for 6.125% Senior Secured Notes due 2029 among Endo Luxembourg Finance Company I S.à r.l., Endo U.S. Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2021
Support Agreement among Endo International plc, Beta Acquisition Corp., and the Marital Trust U/W/O Edwin H. Wegman
Voting Agreements
Endo International plc
Pharmaceuticals
DE
2020
Intercreditor Agreement among Wilmington Trust, Endo International PLC, and Grantors (June 16, 2020)
Trust Agreements
Endo International plc
Pharmaceuticals
NY
2020
Second Lien Collateral Trust Agreement among Endo International PLC, Affiliates, Wells Fargo Bank, and Wilmington Trust (June 16, 2020)
Trust Agreements
Endo International plc
Pharmaceuticals
DE
2020
Collateral Trust Agreement among Endo International PLC, Affiliates, and Wilmington Trust, Dated April 27, 2017
Trust Agreements
Endo International plc
Pharmaceuticals
NY
2020
Supplemental Indenture to 6.000% Senior Notes Due 2025 Among Endo Designated Activity Company, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Supplemental Indenture to 6.000% Senior Notes Due 2023 Among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Indenture for 6.000% Senior Notes due 2028 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
Indenture for 9.500% Senior Secured Second Lien Notes due 2027 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
First Supplemental Indenture to 7.500% Senior Secured Notes Due 2027 – Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2020
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Supplemental Indenture to 7.25% Senior Notes Due 2022 between Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Indenture for 7.500% Senior Secured Notes due 2027 among Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2019
First Amendment, dated as of March 28, 2019 (to the Credit Agreement, dated as of April 27, 2017), by and among Endo International plc, Endo Luxembourg Finance Company I Sarl and...
Credit Agreements
Endo International plc
Pharmaceuticals
NY
2019
Membership Interest and Asset Purchase Agreement between Mendham Holdings, LLC, Endo Ventures Limited, Par Pharmaceutical, Inc., and Seller Related Parties (April 26, 2018)
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2018
Purchase Agreement among Endo Somar Holdings B.V., Affiliates, and AI Global Investments (Netherlands) PCC Limited (Soar Cell) – Grupo Farmacéutico Somar, S.A.P.I. de C.V. Sale
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2017
Purchase Agreement for $300,000,000 5.875% Senior Secured Notes due 2024 by Endo DAC, Endo Finance LLC, and Endo Finco Inc. with Initial Purchasers
Purchase Agreements
Endo International plc
Pharmaceuticals
NY
2017
Amendment No. 2 to Credit Agreement among Endo Luxembourg Finance Company I S.à r.l., Endo LLC, and Deutsche Bank AG New York Branch
Credit Agreements
Endo International plc
Pharmaceuticals
NY
2017
Master Supply Agreement between Jubilant HollisterStier LLC and Endo Ventures Limited
Supply Agreements
Endo International plc
Pharmaceuticals
NY
2016
Amendment to Shareholders Agreement and Registration Rights Agreement among TPG Sky L.P., TPG Sky Co-Invest L.P., TPG Biotechnology Partners IV L.P., and Endo International plc
Modification Agreements
Endo International plc
Pharmaceuticals
2016
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Endo Limited, Affiliates, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 7.25% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2016
Supplemental Indenture for 6.000% Senior Notes Due 2023 among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 Among Endo Finance Entities, Subsidiaries, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 – Guarantor Joinder (Endo Finance LLC et al.)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Par Pharmaceutical Companies, Inc., Subsidiaries, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 Among Endo Finance Entities, Par Pharmaceutical Subsidiaries, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 (Endo Finance LLC and Subsidiaries)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Par Pharmaceutical Subsidiaries, Endo Designated Activity Company, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 – Endo Finance Entities and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 (Endo Finance LLC, Endo Finco Inc., and Ishirini Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.375% Senior Notes Due 2023 among Endo Finance Entities, Guarantors, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 (Endo Finance LLC, Endo Finco Inc., and Ishirini Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015